UNSPSC 85553012: Supplement left lacrimal duct with nonautologous tissue substitute, via natural or artificial opening

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement left lacrimal duct with nonautologous tissue substitute, via natural or artificial opening. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 08UY7KZ

UNSPSC 85553012 (Supplement left lacrimal duct with nonautologous tissue substitute, via natural or artificial opening), a Commodity code, shows no recent state and local procurement activity aligned with its nominal scope of ophthalmic surgical implant procedures. The recent opportunities tagged to this code reflect instead a broad range of unrelated healthcare purchasing: occupational medical surveillance services, pharmacy benefit management, independent medical evaluations for pension disability determinations, surgical procedure carve-out benefit programs, emergency and specialty care for detained youth, and temporary clinical staffing across ancillary healthcare specialties. None of these procurements involves lacrimal duct supplementation or tissue substitutes. The mismatch suggests either systematic misclassification in the issuing bodies' UNSPSC tagging or that the code does not map to material procurement volume in state and local government markets.

The geographic spread of the misdirected opportunities spans Arizona (Phoenix), California (Long Beach and Santa Clara County), Washington (state-level), Florida (Collier County), and Texas (Harris County), with no concentration pattern evident. The issuing bodies include county health systems, county HR and procurement offices, a city retirement office, a state transportation agency, and a county juvenile probation department—a fragmented set of customers with no repeat buyers under this code in the recent block. Given the consistent disconnect between the code's clinical scope and the work actually being solicited, firms should treat this code as inactive for state and local procurement purposes and verify UNSPSC alignment directly with any customer expressing interest in lacrimal or ophthalmic implant supply.